Business Context and Reporting Period
Company: CalciMedica, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 15, 2026
Reporting Period: The filing addresses events occurring between March 16, 2026, and September 14, 2026, specifically regarding Nasdaq listing compliance.
Key Financial Metrics
This filing does not provide financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance status regarding stock price.
Material Changes
- Nasdaq Compliance Status: The Company previously received a notice on March 16, 2026, stating it was non-compliant with Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price below $1.00 for 30 consecutive business days.
- Regain of Compliance: On September 15, 2026, the Company received confirmation from Nasdaq that it regained compliance. The closing bid price was at or above $1.00 per share for 10 consecutive business days (August 31, 2026, to September 14, 2026).
- Current Status: As of the filing date, the Company has no outstanding deficiency notices from Nasdaq.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of financial risks. The primary risk addressed was the potential delisting due to low stock price, which has been resolved as of the report date.
Investor Verification Checklist
- Verify the current trading price of CalciMedica (CALC) on the Nasdaq Capital Market to ensure continued compliance with the $1.00 minimum bid price requirement.
- Confirm that no new deficiency notices have been issued by Nasdaq subsequent to September 15, 2026.
- Review the Company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K does not contain financial metrics.